Omeprazol Sandoz (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Sandoz, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Sandoz is a proton pump inhibitor that acts on the gastric acid secretion pathway.

- Gastro‑oesophageal reflux disease (GERD): Provides symptomatic relief and promotes healing of erosive esophagitis. - Peptic ulcer disease: Facilitates ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: Controls excessive gastric acid secretion associated with the condition. - Helicobacter pylori eradication regimens: Used as part of combination therapy to improve eradication rates. - NSAID‑induced ulcer prophylaxis: Reduces the risk of ulcer development in patients requiring long‑term NSAID therapy.

Omeprazol Sandoz is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: Mild to moderate intensity. - Diarrhea: Usually transient and self‑limiting. - Nausea: May occur shortly after dosing. - Abdominal pain: Cramp‑like discomfort in the stomach region. - Flatulence: Excess gas production. - Constipation: Reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: Severe colitis presenting with watery diarrhea. - Acute interstitial nephritis: Inflammation of kidney interstitium causing renal impairment. - Hypomagnesemia: Low serum magnesium levels leading to muscle cramps or arrhythmias. - Stevens‑Johnson syndrome: Rare severe skin reaction with blistering and mucosal involvement. - Osteoporotic fractures: Increased risk of hip, wrist or spine fractures with long‑term use. - Hepatic injury: Elevated liver enzymes or hepatitis in rare cases.

Before prescribing Omeprazol Sandoz, consider the following precautions:

- Assess renal function: Adjust use in patients with severe renal impairment. - Evaluate hepatic status: Use cautiously in moderate to severe liver disease. - Review long‑term therapy: Monitor for bone density loss with extended use. - Pregnancy and lactation: Weigh benefits against potential risks; consult guidelines. - Drug interactions: Check for concomitant medications that may alter omeprazole metabolism. - Store below 25°C: Keep in the original packaging, protect from moisture and direct sunlight.

Omeprazol Sandoz may interact with several medicines; careful review is advised.

Major Interactions (Avoid): - Clopidogrel: Reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: Decreased absorption of atazanavir, compromising HIV treatment. - Dasatinib: Lowered plasma concentrations, reducing therapeutic efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: Potential increase in INR, requiring more frequent monitoring. - Phenytoin: Enhanced metabolism leading to reduced phenytoin levels. - Methotrexate: Possible increase in serum concentrations, especially at high doses. - Digoxin: Slight increase in serum digoxin levels; monitor for toxicity.